1. Home
  2. World
  3. Omicron variant: UK 1st country to approve Moderna covid-19 vaccine targeting Omicron variant

Omicron variant: UK 1st country to approve Moderna covid-19 vaccine targeting Omicron variant

On Monday, The UK became the first country to approve an updated Moderna vaccine. The UK's drug regulator said it had approved an updated Moderna vaccine against the coronavirus that targets the Omicron variant as well as the original form.

By Priyanka Verma 
Updated Date

London: The United Kingdom has approved the updated modern vaccine (Moderna Vaccine). The UK’s drug regulator said on Monday that he has approved the updated modern vaccine against Corona virus. These are also effective on the original form of virus along with Omicron Variant (Omicron Variant). The UK was the first country to approve this modern vaccine that target Omikron variants.

Also Read :- Albert Bourla, CEO of American pharma co. Pfizer tests +ve for COVID for 2nd time in 6 weeks

In a statement, Medicine & Healthcare Products Regulatory Agency (MHRA) said that he had approved vaccines for its booster dose for Adultus. Modern Vaccine completed the security, quality and effectiveness of the UK regulator. Along with the Omikron variants, there are also a sign of strong immune response against the basic form of virus.

The MHRA also cited an exploratory analysis in which the shot was also found to generate a good immune response against the currently dominant Omicron offshoots BA.4 and BA.5. Half of the Moderna vaccine, called Spikevax bivalent Original/Omicron, targets the original 2020 virus and half the Omicron variant (BA.1).

MHRA chief executive June Raine said in a statement, “The first generation of COVID-19 vaccines being used in the UK continue to provide important protection against the disease and save lives”. The MHRA’s chief executive June Raine said data from a clinical trial had shown it prompted a “strong immune response” against the original virus and Omicron, and would provide a “sharpened tool in our armoury” as the virus kept evolving.

“What this bivalent vaccine gives us is a sharpened tool in our armoury to help protect us against this disease as the virus continues to evolve.” While vaccines have helped lower hospitalisations and deaths from Covid, which first emerged in China in late 2019, the current jabs are mainly aimed at the earlier strains of the disease.

Also Read :- Delhi weather update: Traffic jam due to waterlogging in Delhi, IMD issues rain alert for next two days

The World Health Organization warned in July that the pandemic was “nowhere near over”, due to the spread of Omicron subvariants and to the lifting of control measures. The MHRA said the vaccine was also found to generate a “good response” against two Omicron subvariants, BA.4 and BA.5, which have partly driven a wave of new cases of the disease in Europe and the United States. It also said the vaccine had the same “typically mild” side effects as the original Moderna jab.

Further reading:
For the latest news and reviews, follow us on Facebook, YouTube and Twitter पर फॉलो करे...